Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy
Public ClinicalTrials.gov record NCT06993597. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Development of Robust Corneal Biomechanical Biomarkers for Glaucoma Using Brillouin Microscopy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This pilot study evaluates the biomechanical properties of the cornea in glaucoma patients using Brillouin microscopy, a non-contact imaging technique. The study aims to compare corneal stiffness between patients with normal-tension glaucoma, high-tension glaucoma, and healthy controls, and to assess changes in corneal biomechanics following intraocular pressure (IOP)-lowering treatment. The goal is to determine whether Brillouin-derived biomechanical measurements can serve as biomarkers for glaucoma risk and progression.
Study identification
- NCT ID
- NCT06993597
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Beta Blocker Drug
- Brillouin Microscopy Device
- Prostaglandin Analogue -Containing IOP-Lowering Therapy Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2025
- Primary completion
- Feb 28, 2027
- Completion
- May 31, 2027
- Last update posted
- Aug 9, 2026
2025 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Maryland School of Medicine | Baltimore | Maryland | 21201-1757 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Glaucoma trials
Other public records listing Glaucoma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07425535: Optic Nerve Head Strain in Non-glaucoma Subjects Recruiting
- NCT05726058: Ocular Blood Flow Imaging for Glaucoma Assessment Recruiting
- NCT07588152: Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular Hypertension Not yet recruiting
- NCT07168902: Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension Active, not recruiting
- NCT05523622: Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices Recruiting
- NCT06943599: Strategies for Improving Linkage-to-Care After Eye Disease Screening Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06993597, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2026 · Synced Aug 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06993597 live on ClinicalTrials.gov.